Pfizer and Moderna officials say they are prepared to tweak their vaccines as needed, in as little as six weeks time.
A third variant of the virus, first discovered in Brazil, was now in eight countries, according to the WHO.
Mutant Coronavirus strain found in UK: Is it more dangerous, what does it mean for vaccine, and other FAQs answered
It is anticipated that the vaccine's efficacy will not be significantly hampered by mutations of the Coronavirus strain.
Soreness, light sensitivity and other eye problems likely to occur in COVID-19 patients, suggests study
The researchers could not find any gender differences in these associations between COVID-19 and eye manifestations, suggesting that men and women experienced these problems in the same degree
Viral load found to be higher in asymptomatic COVID-19 patients, lower in those who are older: Study
It took quite a while since the COVID-19 pandemic began for medical professionals to understand the transmissibility of the SARS-CoV-2 virus and how patients with or without symptoms help spread the disease further
The researchers concluded that, to their knowledge, the llama nanobodies they isolated and used to eliminate their SARS-CoV-2 samples are the most potent neutraliser to date
Although diseases like syphilis are treatable, getting a proper diagnosis, medical care and treatment during the pandemic could be more difficult, hence the renewed need to refrain from engaging in risky sexual behaviour.
COVID-19 protection: Redesigned face masks may improve user comfort, effectiveness, says new research
Along with the publication of their study, the researchers are also making the specifications and patterns for their mask available to individuals and manufacturers across the world so that the effective design can be implemented globally.
SARS-CoV-2 strains show little variability, COVID-19 vaccine could be effective against all, finds study
Published in journal 'Frontiers in Microbiology', the study drew from the analysis of 48,635 novel coronavirus genomes, which were isolated in labs all over the world
The virus has the ability to damage the cardiovascular system among other things.
COVID-19 infection less prevalent among newborns, lack of ACE-2 receptors in placenta may shield fetus, claims NIH study
The scientists concluded that the vertical transmission of SARS-CoV-2 virus is very unlikely as there is an absence of the required receptors in the placenta and amniotic sac, especially in the third trimester.
UK study claims COVID-19 immunity may not last over three months; newness of disease causing a paucity of data
The study included about 65 confirmed patients of the novel coronavirus infection and 31 health care workers who showed antibodies against the virus.
Corticosteroid inhalers used by asthma patients may help treat COVID-19, researchers to begin human clinical trials
The ultimate goal of the trial is to analyse if the Budesonide inhaler can be used as a low-cost and easily available early intervention therapy for COVID-19 patients to reduce the risks of severe respiratory illness.
Regeneron begins phase III trials of REGN-COV2; here's how antibody cocktail can help COVID-19 patients
Currently, the antibody cocktail, developed by researchers at the University of Maryland School of Medicine and Regeneron, is in the phase 2 treatment trials stage
US Army study reveals coronavirus can stay active on skin from 8 hours to 14 days depending on temperature
So far there is no evidence on the possible spread of COVID-19 through animal products.
US study claims low dose radiation therapy could help treat pneumonia in COVID-19 patients; results under peer review
Preliminary results of a US study showed that within 24 hours of receiving low-dose radiation therapy, four COVID-19 patients with pneumonia showed rapid improvement in their breathing
COVID-19 treatment: Study suggests cellular nanosponges could restrict SARS-CoV-2 virus multiplication; animal trials underway
Studies conducted by researchers at UC San Diego showed that cellular nanosponges could reduce the ability of SARS-CoV-2 virus that causes COVID-19 disease to infect host cells
The number, or density, of spikes on the mutated virus is 4 or 5 times greater, making it more infectious.
Second wave of COVID-19: What we can learn from 1918 Spanish flu and why caution fatigue is biggest challenge
Many people in India are starting to join millions of people worldwide in wondering about a potential second wave of COVID-19
SARS-CoV-2 can stay active on surfaces for quite a while and touching your face or mask is a bad habit that can increase transmission risks.